NL-OMON48479CompletedNot Applicable
A randomized, double-blind, placebo-controlled single and multiple ascending dose study of the safety, tolerability and pharmacokinetics of oral doses of SAR443122 in healthy adult subjects. - SAD and MAD of SAR443122
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Sanofi-aventis
- Enrollment
- 97
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •healthy male or female subjects
- •18 - 55 years
- •50 - 100 kg
- •BMI 18.0 - 30.0 kg/m2
Exclusion Criteria
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of
- •participation in another drug study within 90 days before the start of this
- •study or being a blood donor within 60 days from the start of the study. In
- •case of donating more than 1.5 liters of blood in the 10 months prior the start
- •of this study.
Investigators
Similar Trials
Terminated
Phase 1
A First-In-Human study to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of NT-0167 in Healthy Volunteers.InflammationInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12620000685910odThera41
Completed
Not Applicable
phase I clinical trial to investigate the safety, tolerability, and pharmacokinetics of HY209 gel as an possible treatment option for atopic dermatitisDiseases of the skin and subcutaneous tissueKCT0003988Shaperon56
Completed
Not Applicable
A randomized, double-blind, placebo-controlled single and multiple ascending dose study to test the safety, tolerability, pharmacokinetics and pharmacodynamics of NT-0167 in healthy volunteersinflammatory disorders and neurodegenerative diseasesinflammatory disordersneurodegenerative diseasesNL-OMON49667odThera80
Completed
Not Applicable
A randomized, double blind, placebo-controlled single ascending dose study on the safety, tolerability, pharmacokinetics and pharmacodynamics of ACT017 in healthy volunteersstrokecerebral infarction10007963NL-OMON44567Acticor Biotech SAS48
Completed
Not Applicable
Evaluation of the effect of choline-stabilized orthosilicic acid on the symptoms of knee osteoarthritisMusculoskeletal DiseasesGonarthrosis [arthrosis of knee]Knee osteoarthritisISRCTN10096951Bio Minerals NV227